- Home
- SEED vs ADXN Comparison
SEED vs ADXN Comparison
Compare SEED & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEED
- ADXN
- Stock Information
- Founded
- SEED 1997
- ADXN 2002
- Country
- SEED China
- ADXN Switzerland
- Employees
- SEED N/A
- ADXN N/A
- Industry
- SEED Farming/Seeds/Milling
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SEED Consumer Staples
- ADXN Health Care
- Exchange
- SEED Nasdaq
- ADXN Nasdaq
- Market Cap
- SEED 8.6M
- ADXN 8.0M
- IPO Year
- SEED N/A
- ADXN N/A
- Fundamental
- Price
- SEED $1.16
- ADXN $10.85
- Analyst Decision
- SEED
- ADXN Strong Buy
- Analyst Count
- SEED 0
- ADXN 1
- Target Price
- SEED N/A
- ADXN $30.00
- AVG Volume (30 Days)
- SEED 93.0K
- ADXN 61.3K
- Earning Date
- SEED 06-26-2025
- ADXN 09-01-2025
- Dividend Yield
- SEED N/A
- ADXN N/A
- EPS Growth
- SEED N/A
- ADXN N/A
- EPS
- SEED N/A
- ADXN 0.10
- Revenue
- SEED $12,910,081.00
- ADXN $278,508.00
- Revenue This Year
- SEED N/A
- ADXN $86.57
- Revenue Next Year
- SEED N/A
- ADXN N/A
- P/E Ratio
- SEED N/A
- ADXN $0.84
- Revenue Growth
- SEED N/A
- ADXN N/A
- 52 Week Low
- SEED $0.74
- ADXN $6.51
- 52 Week High
- SEED $3.59
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- SEED 55.55
- ADXN 68.95
- Support Level
- SEED $1.00
- ADXN $8.88
- Resistance Level
- SEED $1.20
- ADXN $12.05
- Average True Range (ATR)
- SEED 0.10
- ADXN 0.47
- MACD
- SEED 0.00
- ADXN 0.28
- Stochastic Oscillator
- SEED 78.12
- ADXN 72.41
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.